Search Results for:
this is your cancer

Again, the talk of not healthcare reform but rather healthcare payment reform and the interests of lawmakers, physicians, patients, payers and industry at stake with potential significant cost/reimbursement and research budget cuts proposed...

Join Visiopharm at USCAP 2017 and learn about how we are transforming pathology! Come see demonstrations of Analysis of PD-L1 and CD Markers within the Tumor Micro-Environment Visualize and quantify biomarker expression with heatmaps...

Munich, 20 February 2017 -- microDimensions launches a new version of its high precision whole slide alignment software Slidematch. With the new version users can align digital whole slide images from consecutive sections in brightfield and...

Great story in The Pathologist entitled "An Ocean Apart" -- How pathology differs on either side of the Atlantic - and how it doesn't by Michael Schubert What exactly is a boot? Or a biscuit? Or a chip? If you pictured part of a car, a sweet...

Grail, a company that aims to use a blood test to spot cancer, has announced a massive round of funding for its experimental approach. A billion dollars sounds like a lot of money. But when your ambitions are as big as the...

I received a lot of feedback offline about Part 1 of this post (see: “To Sign Out or Not to Sign Out? Part 1” ) from a number of pathologists echoing my sentiments on the issue of turnaround time in general and needs/expectations from...